Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...
Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...
Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...
Background: Endocardial trabecular hyperplasia due to hemodynamic stress reflects phenotypic variability in disease progression. Employing fractal analysis, this study quantified left ventricular (LV) ...
Abstract: Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide. Cardiovascular Magnetic Resonance (CMR) imaging is widely recognized as the gold standard for the non-invasive ...
Second study shows beneficial effects for patients with myocardial infarction and mildly reduced LVEF. Borja Ibanez, M.D., Ph.D., from the Centro Nacional de Investigaciones Cardiovasculares Carlos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback